China
Updated
Reviewed by Vidhi Upadhyay
China Meal Replacement Products Market Industry Trends and Forecast to 2034: Segmented by (Product, Use, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
China · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
China (this report) at $1.06 Bn.
India at 8.9% a year.Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$905.7 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $990.2 Mn | — | — |
| 2025 (base) | $1.06 Bn | +$70.3 Mn | — |
| 2026 (forecast) | $1.14 Bn | +$75.3 Mn | +7.1% |
| 2027 (forecast) | $1.22 Bn | +$80.6 Mn | +14.7% |
| 2028 (forecast) | $1.30 Bn | +$86.4 Mn | +22.8% |
| 2029 (forecast) | $1.40 Bn | +$92.5 Mn | +31.6% |
| 2030 (forecast) | $1.49 Bn | +$99.1 Mn | +40.9% |
| 2031 (forecast) | $1.60 Bn | +$106.1 Mn | +50.9% |
| 2032 (forecast) | $1.71 Bn | +$113.6 Mn | +61.6% |
| 2033 (forecast) | $1.84 Bn | +$121.7 Mn | +73.1% |
| 2034 (forecast) | $1.97 Bn | +$130.3 Mn | +85.4% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US
$6.75 Bn
Canada
$1.30 Bn
China (this report)
$1.06 Bn
Japan
$995.1 Mn
Germany
$570.4 Mn
France
$445.2 Mn
Italy
$362.6 Mn
Brazil
$363.6 Mn
UK
$331.5 Mn
Ecuador
$297.7 Mn
Spain
$258.4 Mn
India
$272.4 Mn
Saudi Arabia
$246.6 Mn
Mexico
$213.3 Mn
Australia
$187.9 Mn
New Zealand
$162.4 Mn
Russia
$151.6 Mn
South Africa
$106.0 Mn
UAE
$66.4 Mn
Egypt
$44.0 Mn
Philippines
$36.6 Mn
Malaysia
$25.6 Mn
Hong Kong
$25.0 Mn
Thailand
$18.1 Mn
Singapore
$16.5 Mn
Kenya
$10.6 Mn
| Market size, 2025 | $1.06 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $1.97 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 7.1% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, use and distribution channel (see all) |
| Key players | Herbalife Nutrition, Abbott Laboratories, Nestle, Glanbia PLC, Huel and 1 more (see all) |
| Regulator in China | NMPA and SAMRSource: National Medical Products Administration. Checked 14 Nov 2026.Source: State Administration for Market Regulation. Checked 14 Nov 2026. |
| Active clinical trials | 2 in ChinaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in China. Retrieved 12 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Meal replacement products are shakes, bars and powders that replace a meal with set calories and nutrients, often used for weight control.
Key segments of the meal Replacement Products market include product (Shakes and Drinks, Powders and Bars) and use (Weight Management, Medical Nutrition and Busy Lifestyles).
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the meal Replacement Products market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.
Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the meal Replacement Products market, especially in fast-growing emerging economies.
High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the meal Replacement Products market. Long-term safety data and lifestyle support are still needed for many patients.
The meal Replacement Products market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Drugs need approval from the National Medical Products Administration (NMPA) before sale.[1] Health foods, sold with a blue-hat logo, must be registered or filed with the State Administration for Market Regulation (SAMR).[2] ClinicalTrials.gov lists 2 studies on Meal Replacement Products that are recruiting, active or about to start in China.[3] Obesity (adults): 9.3% of adults in 2024, the latest WHO figure for China.[4]
[1] National Medical Products Administration. Checked 14 Nov 2026.
[2] State Administration for Market Regulation. Checked 14 Nov 2026.
[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in China. Retrieved 12 Nov 2026.
[4] WHO Global Health Observatory, Obesity (adults) (% of adults). Retrieved 15 Nov 2026.
Food and supplement rules, labelling and health-claim regulations govern meal Replacement Products products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in China.
What doctors and scientists are doing in Meal Replacement Products right now, from free public sources.
2 active trials in China
Recruiting, about to start, or running now.
9.3 % of adults
Obesity (adults), China, 2024 (WHO).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] WHO Global Health Observatory, Obesity (adults) (% of adults). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.
From our blog
China · 2 shared keywords
China · 2 shared keywords
China · 1 shared keyword
China · 1 shared keyword
China · 1 shared keyword
China · 1 shared keyword
Pharmaceuticals · China
Medical Devices · China
Medical Devices · China
Medical Devices · China
Pharmaceuticals · China
Pharmaceuticals · China
